The endocannabinoid system and the molecular basis of paralytic ileus in mice

N. Mascolo, A.A. Izzo, A. Ligresti, A. Costagliela, L. Pinto, M.G. Cascio, P. Maffia, A. Cecio, F. Capasso, V. Di Marzo

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

The endocannabinoid system (i.e., the cannabinoid receptors and their endogenous ligands) plays an important role in the physiological control of intestinal motility. However, its participation in intestinal pathological states is still poorly understood. In the present study, we investigated the possible role of the endocannabinoid system in the pathogenesis of paralytic ileus, a pathological
state consisting of decreased intestinal motility following peritonitis, surgery, or other noxious situations. Ileus was induced by i.p. administration of acetic acid, and gastrointestinal propulsion was assessed by the charcoal method. Endocannabinoid levels were measured by isotope-dilution gas chromatography-mass spectrometry, whereas cannabinoid CB1 receptors were identified by
immunohistochemistry. Acetic acid administration inhibited gastrointestinal transit (ileus), and this effect was accompanied by increased levels of the endocannabinoid anandamide compared with control mice and by overexpression of CB1 receptors in myenteric nerves. Furthermore,
acetic acid-induced ileus was alleviated by the CB1 receptor antagonist SR141716A and worsened by VDM11, a selective inhibitor of anandamide cellular uptake (and hence inactivation). From these findings, it can be concluded that the intestinal hypomotility typical of paralytic ileus is due, at least in part, to the enhancement of anandamide levels and CB1 expression during this condition, and that selective, nonpsychotropic CB1 receptor antagonists could represent new drugs to treat this disorder.
LanguageEnglish
Pages1973-1975
Number of pages3
JournalFASEB Journal
Volume16
DOIs
Publication statusPublished - 2002

Fingerprint

Intestinal Pseudo-Obstruction
Cannabinoid Receptor CB1
Endocannabinoids
Ileus
Acetic Acid
rimonabant
Gastrointestinal Motility
Gastrointestinal Transit
Cannabinoid Receptors
Charcoal
Peritonitis
Isotopes
Gas chromatography
Gas Chromatography-Mass Spectrometry
Surgery
Propulsion
Dilution
Mass spectrometry
Immunohistochemistry
Ligands

Keywords

  • paralytic ileus
  • endocannabinoid system
  • anandamide transport

Cite this

Mascolo, N., Izzo, A. A., Ligresti, A., Costagliela, A., Pinto, L., Cascio, M. G., ... Di Marzo, V. (2002). The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB Journal, 16, 1973-1975. https://doi.org/10.1096/fj.02-0338fje
Mascolo, N. ; Izzo, A.A. ; Ligresti, A. ; Costagliela, A. ; Pinto, L. ; Cascio, M.G. ; Maffia, P. ; Cecio, A. ; Capasso, F. ; Di Marzo, V. / The endocannabinoid system and the molecular basis of paralytic ileus in mice. In: FASEB Journal. 2002 ; Vol. 16. pp. 1973-1975.
@article{d43877f34eaf43d8b097bee0e9dc85a3,
title = "The endocannabinoid system and the molecular basis of paralytic ileus in mice",
abstract = "The endocannabinoid system (i.e., the cannabinoid receptors and their endogenous ligands) plays an important role in the physiological control of intestinal motility. However, its participation in intestinal pathological states is still poorly understood. In the present study, we investigated the possible role of the endocannabinoid system in the pathogenesis of paralytic ileus, a pathological state consisting of decreased intestinal motility following peritonitis, surgery, or other noxious situations. Ileus was induced by i.p. administration of acetic acid, and gastrointestinal propulsion was assessed by the charcoal method. Endocannabinoid levels were measured by isotope-dilution gas chromatography-mass spectrometry, whereas cannabinoid CB1 receptors were identified by immunohistochemistry. Acetic acid administration inhibited gastrointestinal transit (ileus), and this effect was accompanied by increased levels of the endocannabinoid anandamide compared with control mice and by overexpression of CB1 receptors in myenteric nerves. Furthermore, acetic acid-induced ileus was alleviated by the CB1 receptor antagonist SR141716A and worsened by VDM11, a selective inhibitor of anandamide cellular uptake (and hence inactivation). From these findings, it can be concluded that the intestinal hypomotility typical of paralytic ileus is due, at least in part, to the enhancement of anandamide levels and CB1 expression during this condition, and that selective, nonpsychotropic CB1 receptor antagonists could represent new drugs to treat this disorder.",
keywords = "paralytic ileus , endocannabinoid system , anandamide transport",
author = "N. Mascolo and A.A. Izzo and A. Ligresti and A. Costagliela and L. Pinto and M.G. Cascio and P. Maffia and A. Cecio and F. Capasso and {Di Marzo}, V.",
year = "2002",
doi = "10.1096/fj.02-0338fje",
language = "English",
volume = "16",
pages = "1973--1975",
journal = "FASEB Journal",
issn = "0892-6638",

}

Mascolo, N, Izzo, AA, Ligresti, A, Costagliela, A, Pinto, L, Cascio, MG, Maffia, P, Cecio, A, Capasso, F & Di Marzo, V 2002, 'The endocannabinoid system and the molecular basis of paralytic ileus in mice' FASEB Journal, vol. 16, pp. 1973-1975. https://doi.org/10.1096/fj.02-0338fje

The endocannabinoid system and the molecular basis of paralytic ileus in mice. / Mascolo, N.; Izzo, A.A.; Ligresti, A.; Costagliela, A.; Pinto, L.; Cascio, M.G.; Maffia, P.; Cecio, A.; Capasso, F.; Di Marzo, V.

In: FASEB Journal, Vol. 16, 2002, p. 1973-1975.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The endocannabinoid system and the molecular basis of paralytic ileus in mice

AU - Mascolo, N.

AU - Izzo, A.A.

AU - Ligresti, A.

AU - Costagliela, A.

AU - Pinto, L.

AU - Cascio, M.G.

AU - Maffia, P.

AU - Cecio, A.

AU - Capasso, F.

AU - Di Marzo, V.

PY - 2002

Y1 - 2002

N2 - The endocannabinoid system (i.e., the cannabinoid receptors and their endogenous ligands) plays an important role in the physiological control of intestinal motility. However, its participation in intestinal pathological states is still poorly understood. In the present study, we investigated the possible role of the endocannabinoid system in the pathogenesis of paralytic ileus, a pathological state consisting of decreased intestinal motility following peritonitis, surgery, or other noxious situations. Ileus was induced by i.p. administration of acetic acid, and gastrointestinal propulsion was assessed by the charcoal method. Endocannabinoid levels were measured by isotope-dilution gas chromatography-mass spectrometry, whereas cannabinoid CB1 receptors were identified by immunohistochemistry. Acetic acid administration inhibited gastrointestinal transit (ileus), and this effect was accompanied by increased levels of the endocannabinoid anandamide compared with control mice and by overexpression of CB1 receptors in myenteric nerves. Furthermore, acetic acid-induced ileus was alleviated by the CB1 receptor antagonist SR141716A and worsened by VDM11, a selective inhibitor of anandamide cellular uptake (and hence inactivation). From these findings, it can be concluded that the intestinal hypomotility typical of paralytic ileus is due, at least in part, to the enhancement of anandamide levels and CB1 expression during this condition, and that selective, nonpsychotropic CB1 receptor antagonists could represent new drugs to treat this disorder.

AB - The endocannabinoid system (i.e., the cannabinoid receptors and their endogenous ligands) plays an important role in the physiological control of intestinal motility. However, its participation in intestinal pathological states is still poorly understood. In the present study, we investigated the possible role of the endocannabinoid system in the pathogenesis of paralytic ileus, a pathological state consisting of decreased intestinal motility following peritonitis, surgery, or other noxious situations. Ileus was induced by i.p. administration of acetic acid, and gastrointestinal propulsion was assessed by the charcoal method. Endocannabinoid levels were measured by isotope-dilution gas chromatography-mass spectrometry, whereas cannabinoid CB1 receptors were identified by immunohistochemistry. Acetic acid administration inhibited gastrointestinal transit (ileus), and this effect was accompanied by increased levels of the endocannabinoid anandamide compared with control mice and by overexpression of CB1 receptors in myenteric nerves. Furthermore, acetic acid-induced ileus was alleviated by the CB1 receptor antagonist SR141716A and worsened by VDM11, a selective inhibitor of anandamide cellular uptake (and hence inactivation). From these findings, it can be concluded that the intestinal hypomotility typical of paralytic ileus is due, at least in part, to the enhancement of anandamide levels and CB1 expression during this condition, and that selective, nonpsychotropic CB1 receptor antagonists could represent new drugs to treat this disorder.

KW - paralytic ileus

KW - endocannabinoid system

KW - anandamide transport

U2 - 10.1096/fj.02-0338fje

DO - 10.1096/fj.02-0338fje

M3 - Article

VL - 16

SP - 1973

EP - 1975

JO - FASEB Journal

T2 - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

ER -

Mascolo N, Izzo AA, Ligresti A, Costagliela A, Pinto L, Cascio MG et al. The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB Journal. 2002;16:1973-1975. https://doi.org/10.1096/fj.02-0338fje